Cargando…

Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients

INTRODUCTION: Many studies have demonstrated elevated circulating levels of high-mobility group box 1 (HMGB1) and decreased circulating levels of soluble receptor for advanced glycation end products (sRAGE) in patients with autoimmune diseases. In the present study, we investigated plasma levels of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Kuo-Tung, Hsieh, Tsu-Yi, Chao, Ya-Hsuan, Lin, Meng-Xian, Chen, Yi-Hsing, Chen, Der-Yuan, Lin, Chi-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448773/ https://www.ncbi.nlm.nih.gov/pubmed/28558055 http://dx.doi.org/10.1371/journal.pone.0178404

Ejemplares similares

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis
por: de Souza, Alexandre W. S., et al.
Publicado: (2014)

The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still’s disease
por: Chen, Der-Yuan, et al.
Publicado: (2015)

The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
por: Bobek, Dubravka, et al.
Publicado: (2014)

Influence of ADAM10 Polymorphisms on Plasma Level of Soluble Receptor for Advanced Glycation End Products and The Association With Alzheimer’s Disease Risk
por: Huang, Wen-Hui, et al.
Publicado: (2018)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome
por: Lin, Chi-Chien, et al.
Publicado: (2021)

Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome
por: Chao, Ya-Hsuan, et al.
Publicado: (2018)

High-mobility group box 1 facilitates migration of neural stem cells via receptor for advanced glycation end products signaling pathway
por: Xue, Xin, et al.
Publicado: (2018)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
por: Abe, Hiromi, et al.
Publicado: (2023)

Overexpression of Receptor for Advanced Glycation End Products and High-Mobility Group Box 1 in Human Dental Pulp Inflammation
por: Tancharoen, Salunya, et al.
Publicado: (2014)

High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon
por: Schoenfeld, Julia, et al.
Publicado: (2023)

Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies
por: Chen, Jie-Hua, et al.
Publicado: (2018)

Placental growth factor, pregnancy-associated plasma protein-A, soluble receptor for advanced glycation end products, extracellular newly identified receptor for receptor for advanced glycation end products binding protein and high mobility group box 1 levels in patients with acute kidney injury: a cross sectional study
por: Zakiyanov, Oskar, et al.
Publicado: (2013)

Dendritic Cells and Antiphospholipid Syndrome: An Updated Systematic Review
por: Tang, Kuo-Tung, et al.
Publicado: (2021)

Modulation of Vagal Sensory Neurons via High Mobility Group Box-1 and Receptor for Advanced Glycation End Products: Implications for Respiratory Viral Infections
por: Mazzone, Stuart B., et al.
Publicado: (2021)

Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Atherosclerosis: Possible Correlation with Clinical Presentation
por: Falcone, Colomba, et al.
Publicado: (2013)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia
por: Achouiti, Ahmed, et al.
Publicado: (2013)

From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis
por: Mardente, Stefania, et al.
Publicado: (2018)

Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer
por: Zhou, Xiaohai, et al.
Publicado: (2020)

Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect
por: Haddad, Mohamed, et al.
Publicado: (2016)

Changes in Plasma Soluble Receptor for Advanced Glycation End-Products Are Associated with Survival in Patients with Acute Respiratory Distress Syndrome
por: Jabaudon, Matthieu, et al.
Publicado: (2021)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Clinical Value of High Mobility Group Box 1 and the Receptor for Advanced Glycation End-products in Head and Neck Cancer: A Systematic Review
por: Nguyen, Austin, et al.
Publicado: (2016)

High-mobility group box 1 protein is implicated in advanced glycation end products–induced vascular endothelial growth factor A production in the rat retinal ganglion cell line RGC-5
por: Lee, Jong-Jer, et al.
Publicado: (2012)

Soluble Receptor for Advanced Glycation End Product Is Involved in the Inflammatory Response of Human Adenovirus-Infected Patients
por: Xu, Wen, et al.
Publicado: (2022)

High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4
por: Wang, Chen, et al.
Publicado: (2015)

Advanced glycation end products modulate electrophysiological remodeling of right ventricular outflow tract cardiomyocytes: A novel target for diabetes‐related ventricular arrhythmogenesis
por: Chen, Yao‐Chang, et al.
Publicado: (2022)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

High-Mobility Group Box 1 Inhibits Gastric Ulcer Healing through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products
por: Nadatani, Yuji, et al.
Publicado: (2013)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

Integrative Mendelian randomization reveals the soluble receptor for advanced glycation end products as protective in relation to rheumatoid arthritis
por: Lee, Gha Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6im9ocvgji57k7tffb2nrl5so9